Cargando…

KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer

INTRODUCTION: Oncogenic mutation within the KRAS gene represents a negative predictor for treatment response to anti-epidermal growth factor receptor (EGFR) in patients with colorectal cancer. Recently, we have shown no relevant heterogeneity for KRAS mutation status within and between pre- and post...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Peter, Bernhardt, Markus, Nietert, Manuel, König, Alexander, Azizian, Azadeh, Schirmer, Markus A., Grade, Marian, Kitz, Julia, Reuter-Jessen, Kirsten, Ghadimi, Michael, Ströbel, Philipp, Schildhaus, Hans-Ulrich, Gaedcke, Jochen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529221/ https://www.ncbi.nlm.nih.gov/pubmed/33002027 http://dx.doi.org/10.1371/journal.pone.0239806

Ejemplares similares

Heterogeneity of KRAS Mutation Status in Rectal Cancer
por: Jo, Peter, et al.
Publicado: (2016)

Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer
por: Azizian, Azadeh, et al.
Publicado: (2016)

Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy
por: Jo, Peter, et al.
Publicado: (2017)

Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection
por: Bernhardt, Markus, et al.
Publicado: (2023)

Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies
por: Jo, Peter, et al.
Publicado: (2016)

Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer
por: Flebbe, Hannah, et al.
Publicado: (2019)

The molecular basis of chemoradiosensitivity in rectal cancer:implications for personalized therapies
por: Grade, Marian, et al.
Publicado: (2012)

Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy
por: Emons, Georg, et al.
Publicado: (2022)

CA19-9 for detecting recurrence of pancreatic cancer
por: Azizian, Azadeh, et al.
Publicado: (2020)

Incidence, Associated Risk Factors, and Outcomes of Postoperative Arrhythmia After Upper Gastrointestinal Surgery
por: Rühlmann, Felix, et al.
Publicado: (2022)

Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer
por: Gaedcke, Jochen, et al.
Publicado: (2014)

Surgical treatment of metastatic VIPoma: a case report
por: Azizian, Azadeh, et al.
Publicado: (2021)

Incidence and impact of new-onset postoperative arrhythmia after surgery of the lower gastrointestinal tract
por: Rühlmann, Felix, et al.
Publicado: (2023)

Treatment options of metastatic and nonmetastatic VIPoma: a review
por: Azizian, Azadeh, et al.
Publicado: (2022)

Pelvic intraoperative neuromonitoring during robotic-assisted low anterior resection for rectal cancer
por: Grade, Marian, et al.
Publicado: (2015)

Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas
por: Peng, Luogen, et al.
Publicado: (2023)

Personalmanagement und Leadership in der Chirurgie
por: Grade, Marian, et al.
Publicado: (2021)

Distinct Chromosomal Profiles in Metastasizing and Non-Metastasizing Colorectal Carcinomas
por: Ghadimi, B. Michael, et al.
Publicado: (2006)

The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials
por: Gaedcke, J., et al.
Publicado: (2009)

Impact of RNA degradation on gene expression profiling
por: Opitz, Lennart, et al.
Publicado: (2010)

Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy
por: Flebbe, Hannah, et al.
Publicado: (2022)

Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
por: Conradi, Lena-Christin, et al.
Publicado: (2019)

KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
por: PALIOGIANNIS, PANAGIOTIS, et al.
Publicado: (2014)

Standard perioperative management in gastrointestinal surgery
por: Grade, Marian, et al.
Publicado: (2011)

The Impact of Molecular Pathology in Oncology: The Clinician’s Perspective
por: Grade, Marian, et al.
Publicado: (2004)

Effectiveness of fourth-line dual immunotherapy in hepatocellular carcinoma with simultaneous steroid administration for immune-related hepatitis
por: Lowes, Kristina, et al.
Publicado: (2022)

ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells
por: Sen, Madhobi, et al.
Publicado: (2019)

8-Oxoguanine DNA Glycosylase (OGG1) Cys326 Variant: Increased Risk for Worse Outcome of Patients with Locally Advanced Rectal Cancer after Multimodal Therapy
por: Leu, Martin, et al.
Publicado: (2021)

FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis
por: Fromme, Julia Elisabeth, et al.
Publicado: (2018)

UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib
por: Landmann, H, et al.
Publicado: (2014)

Diameter of Superior Rectal Vein – CT Predictor of KRAS Mutation in Rectal Carcinoma
por: Song, Chenyu, et al.
Publicado: (2020)

Molecular Cytogenetics: Genomic Imbalances in Colorectal Cancer and their Clinical Impact
por: Grade, Marian, et al.
Publicado: (2006)

Correspondence and Concordance of Retrospective and Concurrent Responses to Physiotherapists and Sport Psychology Questionnaire Items
por: Groover, Ashlee E., et al.
Publicado: (2022)

The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
por: Rühlmann, Felix, et al.
Publicado: (2017)

Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer
por: Elakad, Omar, et al.
Publicado: (2020)

The Composition and Concordance of Lactobacillus Populations of Infant Gut and the Corresponding Breast-Milk and Maternal Gut
por: Zhang, Xuyao, et al.
Publicado: (2020)

Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment
por: Conradi, Lena-Christin, et al.
Publicado: (2011)

The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness
por: Kari, Vijayalakshmi, et al.
Publicado: (2019)

Characterizing MRI features of rectal cancers with different KRAS status
por: Xu, Yanyan, et al.
Publicado: (2019)

Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy
por: Gattenlöhner, S., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9vosval743v7b1fq84tner9ugg